Rhabdomyosarcoma
Definition:
References:
-
[1]. Elizabeth Charytonowicz, et al. Alveolar rhabdomyosarcoma: is the cell of origin a mesenchymal stem cell?. Cancer Lett. 2009 Jul 8;279(2):126-36. [Content Brief]
[2]. G D Letson, et al. Genetic and molecular abnormalities in tumors of the bone and soft tissues. Cancer Control. 2001 May-Jun;8(3):239-51. [Content Brief]
[3]. Ken Kikuchi, et al. MDM2 Amplification and PI3KCA Mutation in a Case of Sclerosing Rhabdomyosarcoma. Sarcoma. 2013;2013:520858. [Content Brief]
[4]. L Krsková, et al. Rhabdomyosarcoma: molecular diagnostics of patients classified by morphology and immunohistochemistry with emphasis on bone marrow and purged peripheral blood progenitor cells involvement. Virchows Arch. 2006 Apr;448(4):449-58. [Content Brief]
[5]. Lee J Helman, et al. Mechanisms of sarcoma development. Nat Rev Cancer. 2003 Sep;3(9):685-94. [Content Brief]
[6]. Shujuan J Xia, et al. Molecular pathogenesis of rhabdomyosarcoma. Cancer Biol Ther. 2002 Mar-Apr;1(2):97-104. [Content Brief]
[7]. Steffen Albrecht, et al. Allelic loss but absence of mutations in the polyspecific transporter gene BWR1A on 11p15.5 in hepatoblastoma. Int J Cancer. 2004 Sep 10;111(4):627-32. [Content Brief]
[8]. William D Foulkes, et al. Extending the phenotypes associated with DICER1 mutations. Hum Mutat. 2011 Dec;32(12):1381-4. [Content Brief]